Seven Grand Managers’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
Seven Grand Managers's TSHA Position: Q3 2026 in Review
Seven Grand Managers opened a new position in Taysha Gene Therapies (TSHA) in Q3 2026: 500,000 shares worth $2.44M. The stake represents 0.09% of the portfolio and ranks #104 among its holdings.
205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.
- Seven Grand Managers held 500,000 shares of Taysha Gene Therapies worth $2.44M as of Q3 2026.
- Taysha Gene Therapies was a new Seven Grand Managers position in Q3 2026.
- Taysha Gene Therapies made up 0.09% of Seven Grand Managers's portfolio in Q3 2026, its #104 holding.
- 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.
Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.